Page 37 - AN-1-1

Advanced Neurology Gastrointestinal symptoms in PD

disease. Clin Neurol Neurosurg, 2021: 106447. Parkinson’s disease. Brain, 135(Pt 5): 1478–1485.
https://doi.org/10.1016/j.clineuro.2020.106447 https://doi.org/10.1093/brain/aws086
48. Monteiro L, Souza-Machado A, Valderramas S, et al., 2012. 59. Jayanthi NV, Dexter SP, Sarela AI, et al., 2013, Gastric
The effect of levodopa on pulmonary function in Parkinson’s electrical stimulation for treatment of clinically severe
disease: A systematic review and meta-analysis. Clin Ther, gastroparesis. J Minim Access Surg, 9(4): 163–167.
34(5): 1049–1055.
https://doi.org/10.4103/0972-9941.118833
https://doi.org/10.1016/j.clinthera.2012.03.001
60. Drossman DA, Dumitrascu DL, 2006, Rome III: New
49. Oh E, Jee S, Kim BK, et al., 2021. A new swallowing standard for functional gastrointestinal disorders.
supplement for dysphagia in patients with Parkinson’s J Gastrointestin Liver Dis, 15(3): 237–241.
disease. Neurol Sci, 42(5): 1949–1958.
61. Huang H, Xu H, Luo Q, et al., 2019, Fecal microbiota
https://doi.org/10.1007/s10072-020-04730-w transplantation to treat Parkinson’s disease with constipation:
A case report. Medicine, 98(26): e16163.
50. Park A, Jang SJ, Kim NE, et al., 2021, Swallowing outcomes
following voice therapy in multiple system atrophy https://doi.org/10.1097/MD.0000000000016163
with dysphagia: Comparison of treatment efficacy with 62. Damian A, Adler CH, Hentz JG, et al., 2012, Autonomic
Parkinson’s disease. Dysphagia, 37(1): 198–206.
function, as self-reported on the SCOPA-autonomic
https://doi.org/10.1007/s00455-021-10265-9 questionnaire, is normal in essential tremor but not in
Parkinson’s disease. Parkinsonism Relat Disord, 18(10):
51. Born LJ, Harned RH, Rikkers LF, et al., 1996, Cricopharyngeal 1089–1093.
dysfunction in Parkinson’s disease: Role in dysphagia and
response to myotomy. Movement Disord, 11(1): 53–58. https://doi.org/10.1016/j.parkreldis.2012.06.008
https://doi.org/10.1002/mds.870110110 63. Forjaz MJ, Ayala A, Rodriguez-Blazquez C, et al., 2010,
Assessing autonomic symptoms of Parkinson’s disease with
52. Restivo DA, Palmeri A, Marchese-Ragona R, 2002,
Botulinum toxin for cricopharyngeal dysfunction in the SCOPA-AUT: A new perspective from Rasch analysis.
Parkinson’s disease. N Engl J Med, 346(15): 1174–1175. Eur J Neurol, 17(2): 273–279.
https://doi.org/10.1111/j.1468-1331.2009.02835.x
https://doi.org/10.1056/NEJM200204113461517
64. Chaudhuri KR, Martinez-Martin P, Brown RG, et al., 2007,
53. Quigley EM, 1996, Gastrointestinal dysfunction in The metric properties of a novel non-motor symptoms scale
Parkinson’s disease. Semin Neurol, 16(3): 245–250.
for Parkinson’s disease: Results from an international pilot
https://doi.org/10.1055/s-2008-1040981 study. Movement Disord, 22(13): 1901–1911.
54. Larson JM, Tavakkoli A, Drane WE, et al., 2010, Advantages https://doi.org/10.1002/mds.21596
of azithromycin over erythromycin in improving the gastric
emptying half-time in adult patients with gastroparesis. 65. De Pablo-Fernandez E, Passananti V, Zarate-Lopez N, et al.,
2019, Colonic transit, high-resolution anorectal manometry
J Neurogastroenterol Motil, 16(4): 407–413.
and MRI defecography study of constipation in Parkinson’s
https://doi.org/10.5056/jnm.2010.16.4.407 disease. Parkinsonism Relat Disord, 66: 195–201.
55. Doi H, Sakakibara R, Sato M, et al., 2014, Nizatidine https://doi.org/10.1016/j.parkreldis.2019.08.016
ameliorates gastroparesis in Parkinson’s disease: A pilot 66. Edwards LL, Quigley EM, Harned RK, et al., 1994,
study. Movement Disord, 29(4): 562–566.
Characterization of swallowing and defecation in Parkinson’s
https://doi.org/10.1002/mds.25777 disease. Am J Gastroenterol, 89(1): 15–25.
56. McCallum RW, Lembo A, Esfandyari T, et al., 2013, Phase 67. Barichella M, Pacchetti C, Bolliri C, et al., 2016, Probiotics
2b, randomized, double-blind 12-week studies of TZP– and prebiotic fiber for constipation associated with
102, a ghrelin receptor agonist for diabetic gastroparesis. Parkinson disease: An RCT. Neurology, 87(12): 1274–1280.
Neurogastroenterol Motil, 25(11): e705–e717.
https://doi.org/10.1212/WNL.0000000000003127
https://doi.org/10.1111/nmo.12184
68. Tan AH, Lim SY, Chong KK, et al., 2021, Probiotics for
57. Brinck CE, Mark EB, Klinge MW, et al., 2020, Magnetic constipation in Parkinson disease: A randomized placebo-
tracking of gastrointestinal motility. Physiol Meas, 41(12): controlled study. Neurology, 96(5): e772–e782.
12TR01.
https://doi.org/10.1212/WNL.0000000000010998
https://doi.org/10.1088/1361-6579/abcd1e
69. Cassani E, Privitera G, Pezzoli G, et al., 2011, Use of
58. Arai E, Arai M, Uchiyama T, et al., 2012, Subthalamic probiotics for the treatment of constipation in Parkinson’s
deep brain stimulation can improve gastric emptying in disease patients. Min Gastroenterol Dietol., 57(2): 117–121.

Volume 1 Issue 1 (2022) 13 https://doi.org/10.36922/an.v1i1.9